This topic contains a solution. Click here to go to the answer

Author Question: A patient is being treated with caspofungin for a systemic fungal infection related to Aspergillus. ... (Read 18 times)

biggirl4568

  • Hero Member
  • *****
  • Posts: 551
A patient is being treated with caspofungin for a systemic fungal infection related to Aspergillus. Prior to the administration of the first parenteral dose, the nurse notes that the patient's AST and ALT levels are elevated.
 
  How will these serum hepatic enzymes affect the administration of caspofungin?
  A) The dose will need to be increased.
  B) The dose will need to be decreased.
  C) The dose will require a serum trough.
  D) The medication should not be given.

Question 2

A patient presents with severe headache and pain in the effected sinus area. The nurse suspects the patient has _________________.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jayson

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

B

Answer to Question 2

Rhinitis




biggirl4568

  • Member
  • Posts: 551
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


connor417

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Excellent

 

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library